Foldax reports one-year outcomes from trial of TRIA mitral valve
2 Articles
2 Articles
One-year results show positive safety and haemodynamic performance for biopolymer surgical mitral valve - Cardiovascular News
Isaac George Foldax has announced the presentation of one-year results from the India clinical trial of the Tria mitral valve, showing a good safety profile, sustained haemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicentre clinical study of a polymer heart valve worldwide, the company says in a press release. The results were presented…
Foldax reports one-year outcomes from trial of TRIA mitral valve
Foldax has revealed one-year outcomes from the India Clinical Trial of the TRIA mitral valve, presented at New York Valves 2025.The post Foldax reports one-year outcomes from trial of TRIA mitral valve appeared first on Medical Device Network.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium